Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer

Technology appraisal guidance
Reference number: TA741
Published: 28 October 2021

Appraisal consultation document (PDF version) (PDF 476 KB)

Published:

20 May 2021
Appraisal consultation document (online commenting)
Committee papers (PDF 9.47 MB)

Published:

20 May 2021
Committee papers slides (PDF 2.1 MB)

Published:

20 May 2021

This page was last updated: 04 November 2021